Ingro Finanz Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Investments
-
3
- Exits
-
2
Ingro Finanz General Information
Company Description
Ingro Finanz is a venture capital firm based in Nidwalden, Switzerland.
Business Details
Investor Status
Primary Investor Type
Corporate Office
- Sonnhaldenstrasse 20
- Hergiswil North West
- 6052 Nidwalden
- Switzerland
Ingro Finanz Investments (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Spexis | 12-Apr-2017 | PE Growth/Expansion | Drug Discovery | Generating Revenue | ||
| Spexis | 17-Jun-2010 | Drug Discovery | Generating Revenue | |||
| Ganymed Pharmaceuticals | 18-Apr-2007 | Drug Discovery | Generating Revenue |
Ingro Finanz Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Spexis | 15-May-2018 | IPO | |
| Ganymed Pharmaceuticals | 21-Aug-2008 |
Ingro Finanz Investments by Industry, Year, and Region
Ingro Finanz FAQs
-
What is Ingro Finanz?
Ingro Finanz is a venture capital firm based in Nidwalden, Switzerland.
-
Where is Ingro Finanz headquartered?
Ingro Finanz is headquartered in Nidwalden, Switzerland.
-
How many investments has Ingro Finanz made?
Ingro Finanz has made 3 investments.
-
What has Ingro Finanz invested in?
Ingro Finanz has made numerous investments in companies like Spexis and Ganymed Pharmaceuticals within the Drug Discovery industry.
-
What has Ingro Finanz invested in recently?
Ingro Finanz's latest investment was on 12-Apr-2017 in Spexis, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process